These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 28431809)
1. Pilot Study of Changes in Presepsin Concentrations Compared With Changes in Procalcitonin and C-Reactive Protein Concentrations After Cardiovascular Surgery. Saito J; Hashiba E; Mikami A; Kudo T; Niwa H; Hirota K J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1262-1267. PubMed ID: 28431809 [TBL] [Abstract][Full Text] [Related]
2. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis. Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis. Ozdemir AA; Elgormus Y Am J Perinatol; 2017 May; 34(6):550-556. PubMed ID: 27825177 [No Abstract] [Full Text] [Related]
4. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study. Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405 [TBL] [Abstract][Full Text] [Related]
5. Presepsin as a predictor of septic shock in patients with urinary tract infection. Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833 [TBL] [Abstract][Full Text] [Related]
6. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study. Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Aouifi A; Piriou V; Bastien O; Blanc P; Bouvier H; Evans R; Célard M; Vandenesch F; Rousson R; Lehot JJ Crit Care Med; 2000 Sep; 28(9):3171-6. PubMed ID: 11008977 [TBL] [Abstract][Full Text] [Related]
8. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy. Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302 [TBL] [Abstract][Full Text] [Related]
9. Changes in presepsin concentrations in surgical patients with end-stage kidney disease undergoing living kidney transplantation: a pilot study. Saito J; Hashiba E; Kushikata T; Mikami A; Hirota K J Anesth; 2016 Feb; 30(1):174-7. PubMed ID: 26275872 [TBL] [Abstract][Full Text] [Related]
10. Serial measurement of presepsin, procalcitonin, and C-reactive protein in the early postoperative period and the response to antithymocyte globulin administration after heart transplantation. Franeková J; Sečník P; Lavríková P; Kubíček Z; Hošková L; Kieslichová E; Jabor A Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27859613 [TBL] [Abstract][Full Text] [Related]
11. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404 [TBL] [Abstract][Full Text] [Related]
12. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590 [TBL] [Abstract][Full Text] [Related]
13. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children. McMaster P; Park DY; Shann F; Cochrane A; Morris K; Gray J; Cottrell S; Belcher J Pediatr Crit Care Med; 2009 Mar; 10(2):217-21. PubMed ID: 19057447 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies. Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789 [TBL] [Abstract][Full Text] [Related]
15. Perioperative plasmatic presepsin levels in patients undergoing total hip or knee replacement: a preliminary study. Vicenti G; Pesce V; Bizzoca D; Nappi V; Palmiotto F; Carrozzo M; Moretti B J Biol Regul Homeost Agents; 2017; 31(4):1081-1086. PubMed ID: 29254318 [TBL] [Abstract][Full Text] [Related]
17. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients. Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts). Loebe M; Locziewski S; Brunkhorst FM; Harke C; Hetzer R Intensive Care Med; 2000 Mar; 26 Suppl 2():S193-8. PubMed ID: 18470719 [TBL] [Abstract][Full Text] [Related]
20. Presepsin and Procalcitonin Levels as Markers of Adverse Postoperative Complications and Mortality in Cardiac Surgery Patients. Clementi A; Virzì GM; Muciño-Bermejo MJ; Nalesso F; Giavarina D; Carta M; Brocca A; de Cal M; Hinna Danesi T; Zanella M; Marchionna N; Brendolan A; Battaglia GG; Salvador L; Ronco C Blood Purif; 2019; 47(1-3):140-148. PubMed ID: 30336490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]